Anirban Maitra: A valuable cancer glycoproteomics data resource from Thomas Kislinger
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared on X:
“A valuable cancer glycoproteomics data resource from Thomas Kislinger. Preprint and annotated website (GlycoPDXplorer) links below. Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers.
Preprint Link and GlycoPDXplorer.”
Authors: Meinusha Govindarajan, Salvador Mejia-Guerrero, Shawn C Chafe, Shahbaz Khan, Wei Shi, Matthew Waas, Amanda Khoo, Lydia Y Liu, Vladimir Ignatchenko, Simona Principe, Lusia Sepiashvili, Nazanin Tatari, Chitra Venugopal, Petar Miletic, Max Topley, Shan Grewal, Dillon McKenna, Maria-Jose Sandi, Nhu-An Pham, Alison Casey, Hyeyeon Kim, Christina Karamboulas, Jalna Meens, Peter Bergqvist, Begonia Silva, Patrick Chan, Liza Cerna-Portillo, Jasmine Chin, Abilasha Rao-Bhatia, Ming-Sound Tsao, Rama Khokha, Susie Su, Wei Xu, David Goldstein, Laurie Ailles, Vuk Stambolic, Fei-Fei Liu, Emma Cummins, Ismael Samudio, Sheila K Singh, Thomas Kislinger
Dr. Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023